COVID-19 Infection and Risk for Neuropsychiatric Symptoms.

Bigos, Kristin L; Goldensohn, Andrea M

Bigos, Kristin L; Goldensohn, Andrea M.

Bigos KL; Department of Medicine, Division of Clinical Pharmacology, Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: kbigos1@jhu.edu.
Goldensohn AM; private practice.

Biol Psychiatry ; 92(7): 528-529, 2022 10 01.

Article in English | MEDLINE | ID: covidwho-2252234

Subject(s)

COVID-19; Mental Disorders; Humans; Mental Disorders/complications; Mental Disorders/psychology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mental Disorders Type of study: Prognostic study / Qualitative research Topics: Long Covid Limits: Humans Language: English Journal: Biol Psychiatry Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google